<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-10-07" version="223">
<accession>Q13285</accession>
<accession>O15196</accession>
<accession>Q5T6F5</accession>
<name>STF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Steroidogenic factor 1</fullName>
<shortName>SF-1</shortName>
<shortName>STF-1</shortName>
<shortName evidence="31">hSF-1</shortName>
</recommendedName>
<alternativeName>
<fullName>Adrenal 4-binding protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Fushi tarazu factor homolog 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor subfamily 5 group A member 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Steroid hormone receptor Ad4BP</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NR5A1</name>
<name type="synonym">AD4BP</name>
<name type="synonym">FTZF1</name>
<name type="synonym">SF1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Biochem. Biophys. Res. Commun." volume="226" first="261" last="267">
<title>Structural characterization of human Ad4bp (SF-1) gene.</title>
<authorList>
<person name="Oba K."/>
<person name="Yanase T."/>
<person name="Nomura M."/>
<person name="Morohashi K."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8806624"/>
<dbReference type="DOI" id="10.1006/bbrc.1996.1343"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Mol. Endocrinol." volume="17" first="139" last="147">
<title>Cloning and sequence analysis of the human gene encoding steroidogenic factor 1.</title>
<authorList>
<person name="Wong M."/>
<person name="Ramayya M.S."/>
<person name="Chrousos G.P."/>
<person name="Driggers P.H."/>
<person name="Parker K.L."/>
</authorList>
<dbReference type="PubMed" id="8938589"/>
<dbReference type="DOI" id="10.1677/jme.0.0170139"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="1997-04" db="EMBL/GenBank/DDBJ databases">
<title>Cloning and characterization of the human steroidogenic factor 1 (SF-1) cDNA.</title>
<authorList>
<person name="Santa Barbara P."/>
<person name="Desclozeaux M."/>
<person name="Boizet B."/>
<person name="Bonneaud N."/>
<person name="Laudet V."/>
<person name="Poulat F."/>
<person name="Berta P."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="1995-07" db="EMBL/GenBank/DDBJ databases">
<title>Human SF1 genomic segment.</title>
<authorList>
<person name="Yeh J.R."/>
<person name="Chung B.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 20-75</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1997" name="J. Clin. Endocrinol. Metab." volume="82" first="1799" last="1806">
<title>Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies.</title>
<authorList>
<person name="Ramayya M.S."/>
<person name="Zhou J."/>
<person name="Kino T."/>
<person name="Segars J.H."/>
<person name="Bondy C.A."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="9177385"/>
<dbReference type="DOI" id="10.1210/jcem.82.6.3967"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Mol. Cell" volume="3" first="521" last="526">
<title>Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress.</title>
<authorList>
<person name="Hammer G.D."/>
<person name="Krylova I."/>
<person name="Zhang Y."/>
<person name="Darimont B.D."/>
<person name="Simpson K."/>
<person name="Weigel N.L."/>
<person name="Ingraham H.A."/>
</authorList>
<dbReference type="PubMed" id="10230405"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80480-3"/>
</citation>
<scope>PHOSPHORYLATION AT SER-203</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="37659" last="37664">
<title>Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5.</title>
<authorList>
<person name="Jacob A.L."/>
<person name="Lund J."/>
<person name="Martinez P."/>
<person name="Hedin L."/>
</authorList>
<dbReference type="PubMed" id="11479297"/>
<dbReference type="DOI" id="10.1074/jbc.m104427200"/>
</citation>
<scope>ACETYLATION AT LYS-34; LYS-38 AND LYS-72</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Endocrinology" volume="143" first="1280" last="1290">
<title>Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.</title>
<authorList>
<person name="Sewer M.B."/>
<person name="Nguyen V.Q."/>
<person name="Huang C.J."/>
<person name="Tucker P.W."/>
<person name="Kagawa N."/>
<person name="Waterman M.R."/>
</authorList>
<dbReference type="PubMed" id="11897684"/>
<dbReference type="DOI" id="10.1210/endo.143.4.8748"/>
</citation>
<scope>INTERACTION WITH SFPQ</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH SFPQ AND NONO</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Mol. Endocrinol." volume="18" first="2451" last="2462">
<title>Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.</title>
<authorList>
<person name="Komatsu T."/>
<person name="Mizusaki H."/>
<person name="Mukai T."/>
<person name="Ogawa H."/>
<person name="Baba D."/>
<person name="Shirakawa M."/>
<person name="Hatakeyama S."/>
<person name="Nakayama K.I."/>
<person name="Yamamoto H."/>
<person name="Kikuchi A."/>
<person name="Morohashi K."/>
</authorList>
<dbReference type="PubMed" id="15192080"/>
<dbReference type="DOI" id="10.1210/me.2004-0173"/>
</citation>
<scope>SUMOYLATION AT LYS-119 AND LYS-194</scope>
<scope>MUTAGENESIS OF LYS-119 AND LYS-194</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="2027" last="2036">
<title>Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain-interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation.</title>
<authorList>
<person name="Lan H.-C."/>
<person name="Li H.-J."/>
<person name="Lin G."/>
<person name="Lai P.-Y."/>
<person name="Chung B.-C."/>
</authorList>
<dbReference type="PubMed" id="17210646"/>
<dbReference type="DOI" id="10.1128/mcb.02253-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HIPK3</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="6669" last="6685">
<title>Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17.</title>
<authorList>
<person name="Li D."/>
<person name="Urs A.N."/>
<person name="Allegood J."/>
<person name="Leon A."/>
<person name="Merrill A.H. Jr."/>
<person name="Sewer M.B."/>
</authorList>
<dbReference type="PubMed" id="17664281"/>
<dbReference type="DOI" id="10.1128/mcb.00355-07"/>
</citation>
<scope>INTERACTION WITH DGKQ</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Mol. Endocrinol." volume="22" first="91" last="104">
<title>Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7.</title>
<authorList>
<person name="Lewis A.E."/>
<person name="Rusten M."/>
<person name="Hoivik E.A."/>
<person name="Vikse E.L."/>
<person name="Hansson M.L."/>
<person name="Wallberg A.E."/>
<person name="Bakke M."/>
</authorList>
<dbReference type="PubMed" id="17901130"/>
<dbReference type="DOI" id="10.1210/me.2006-0478"/>
</citation>
<scope>PHOSPHORYLATION AT SER-203</scope>
<scope>INTERACTION WITH CDK7</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="613" last="625">
<title>SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.</title>
<authorList>
<person name="Yang W.-H."/>
<person name="Heaton J.H."/>
<person name="Brevig H."/>
<person name="Mukherjee S."/>
<person name="Iniguez-Lluhi J.A."/>
<person name="Hammer G.D."/>
</authorList>
<dbReference type="PubMed" id="19015234"/>
<dbReference type="DOI" id="10.1128/mcb.00295-08"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>PHOSPHORYLATION AT SER-203</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Cell" volume="120" first="343" last="355">
<title>Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1.</title>
<authorList>
<person name="Krylova I.N."/>
<person name="Sablin E.P."/>
<person name="Moore J."/>
<person name="Xu R.X."/>
<person name="Waitt G.M."/>
<person name="MacKay J.A."/>
<person name="Juzumiene D."/>
<person name="Bynum J.M."/>
<person name="Madauss K."/>
<person name="Montana V."/>
<person name="Lebedeva L."/>
<person name="Suzawa M."/>
<person name="Williams J.D."/>
<person name="Williams S.P."/>
<person name="Guy R.K."/>
<person name="Thornton J.W."/>
<person name="Fletterick R.J."/>
<person name="Willson T.M."/>
<person name="Ingraham H.A."/>
</authorList>
<dbReference type="PubMed" id="15707893"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.01.024"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 222-461 IN COMPLEX WITH NCOA2 AND PHOSPHOLIPID</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="7505" last="7510">
<title>The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1.</title>
<authorList>
<person name="Wang W."/>
<person name="Zhang C."/>
<person name="Marimuthu A."/>
<person name="Krupka H.I."/>
<person name="Tabrizizad M."/>
<person name="Shelloe R."/>
<person name="Mehra U."/>
<person name="Eng K."/>
<person name="Nguyen H."/>
<person name="Settachatgul C."/>
<person name="Powell B."/>
<person name="Milburn M.V."/>
<person name="West B.L."/>
</authorList>
<dbReference type="PubMed" id="15897460"/>
<dbReference type="DOI" id="10.1073/pnas.0409482102"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 221-461 IN COMPLEX WITH NCOA2 AND PHOSPHOLIPID</scope>
<scope>MUTAGENESIS OF ALA-269; GLY-341; LEU-344; ALA-433; TYR-436 AND LYS-440</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="125" last="126">
<title>A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans.</title>
<authorList>
<person name="Achermann J.C."/>
<person name="Ito M."/>
<person name="Ito M."/>
<person name="Hindmarsh P.C."/>
<person name="Jameson J.L."/>
</authorList>
<dbReference type="PubMed" id="10369247"/>
<dbReference type="DOI" id="10.1038/9629"/>
</citation>
<scope>VARIANT SRXY3 GLU-35</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="67" first="1563" last="1568">
<title>Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency.</title>
<authorList>
<person name="Biason-Lauber A."/>
<person name="Schoenle E.J."/>
</authorList>
<dbReference type="PubMed" id="11038323"/>
<dbReference type="DOI" id="10.1086/316893"/>
</citation>
<scope>VARIANT AINR LEU-255</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="1829" last="1833">
<title>Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner.</title>
<authorList>
<person name="Achermann J.C."/>
<person name="Ozisik G."/>
<person name="Ito M."/>
<person name="Orun U.A."/>
<person name="Harmanci K."/>
<person name="Gurakan B."/>
<person name="Jameson J.L."/>
</authorList>
<dbReference type="PubMed" id="11932325"/>
<dbReference type="DOI" id="10.1210/jcem.87.4.8376"/>
</citation>
<scope>VARIANT SRXY3 GLN-92</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="J. Clin. Endocrinol. Metab." volume="92" first="991" last="999">
<title>Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.</title>
<authorList>
<person name="Lin L."/>
<person name="Philibert P."/>
<person name="Ferraz-de-Souza B."/>
<person name="Kelberman D."/>
<person name="Homfray T."/>
<person name="Albanese A."/>
<person name="Molini V."/>
<person name="Sebire N.J."/>
<person name="Einaudi S."/>
<person name="Conway G.S."/>
<person name="Hughes I.A."/>
<person name="Jameson J.L."/>
<person name="Sultan C."/>
<person name="Dattani M.T."/>
<person name="Achermann J.C."/>
</authorList>
<dbReference type="PubMed" id="17200175"/>
<dbReference type="DOI" id="10.1210/jc.2006-1672"/>
</citation>
<scope>VARIANTS SRXY3 MET-15; ILE-78; SER-91 AND GLN-437</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Hum. Mutat." volume="29" first="59" last="64">
<title>Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.</title>
<authorList>
<person name="Koehler B."/>
<person name="Lin L."/>
<person name="Ferraz-de-Souza B."/>
<person name="Wieacker P."/>
<person name="Heidemann P."/>
<person name="Schroeder V."/>
<person name="Biebermann H."/>
<person name="Schnabel D."/>
<person name="Grueters A."/>
<person name="Achermann J.C."/>
</authorList>
<dbReference type="PubMed" id="17694559"/>
<dbReference type="DOI" id="10.1002/humu.20588"/>
</citation>
<scope>VARIANTS SRXY3 SER-33 AND HIS-84</scope>
<scope>VARIANT ALA-146</scope>
<scope>CHARACTERIZATION OF VARIANTS SRXY3 SER-33 AND HIS-84</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="N. Engl. J. Med." volume="360" first="1200" last="1210">
<title>Mutations in NR5A1 associated with ovarian insufficiency.</title>
<authorList>
<person name="Lourenco D."/>
<person name="Brauner R."/>
<person name="Lin L."/>
<person name="De Perdigo A."/>
<person name="Weryha G."/>
<person name="Muresan M."/>
<person name="Boudjenah R."/>
<person name="Guerra-Junior G."/>
<person name="Maciel-Guerra A.T."/>
<person name="Achermann J.C."/>
<person name="McElreavey K."/>
<person name="Bashamboo A."/>
</authorList>
<dbReference type="PubMed" id="19246354"/>
<dbReference type="DOI" id="10.1056/nejmoa0806228"/>
</citation>
<scope>VARIANTS POF7 ALA-123; LEU-129; 231-LEU--LEU-233 DEL AND ASN-293</scope>
<scope>VARIANT ALA-146</scope>
<scope>CHARACTERIZATION OF VARIANTS POF7 ALA-123; LEU-129 AND ASN-293</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Am. J. Hum. Genet." volume="87" first="505" last="512">
<title>Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1.</title>
<authorList>
<person name="Bashamboo A."/>
<person name="Ferraz-de-Souza B."/>
<person name="Lourenco D."/>
<person name="Lin L."/>
<person name="Sebire N.J."/>
<person name="Montjean D."/>
<person name="Bignon-Topalovic J."/>
<person name="Mandelbaum J."/>
<person name="Siffroi J.P."/>
<person name="Christin-Maitre S."/>
<person name="Radhakrishna U."/>
<person name="Rouba H."/>
<person name="Ravel C."/>
<person name="Seeler J."/>
<person name="Achermann J.C."/>
<person name="McElreavey K."/>
</authorList>
<dbReference type="PubMed" id="20887963"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2010.09.009"/>
</citation>
<scope>VARIANTS SPGF8 ALA-123; LEU-129; LEU-131; CYS-191; SER-212 AND ASN-238</scope>
<scope>CHARACTERIZATION OF VARIANTS SPGF8 LEU-131; CYS-191; SER-212 AND ASN-238</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="BMC Med. Genet." volume="15" first="7" last="7">
<title>The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency.</title>
<authorList>
<person name="Fabbri H.C."/>
<person name="de Andrade J.G."/>
<person name="Soardi F.C."/>
<person name="de Calais F.L."/>
<person name="Petroli R.J."/>
<person name="Maciel-Guerra A.T."/>
<person name="Guerra-Junior G."/>
<person name="de Mello M.P."/>
</authorList>
<dbReference type="PubMed" id="24405868"/>
<dbReference type="DOI" id="10.1186/1471-2350-15-7"/>
</citation>
<scope>VARIANT SRXY3 TYR-65</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="J. Clin. Endocrinol. Metab." volume="101" first="284" last="292">
<title>Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort.</title>
<authorList>
<person name="Guran T."/>
<person name="Buonocore F."/>
<person name="Saka N."/>
<person name="Ozbek M.N."/>
<person name="Aycan Z."/>
<person name="Bereket A."/>
<person name="Bas F."/>
<person name="Darcan S."/>
<person name="Bideci A."/>
<person name="Guven A."/>
<person name="Demir K."/>
<person name="Akinci A."/>
<person name="Buyukinan M."/>
<person name="Aydin B.K."/>
<person name="Turan S."/>
<person name="Agladioglu S.Y."/>
<person name="Atay Z."/>
<person name="Abali Z.Y."/>
<person name="Tarim O."/>
<person name="Catli G."/>
<person name="Yuksel B."/>
<person name="Akcay T."/>
<person name="Yildiz M."/>
<person name="Ozen S."/>
<person name="Doger E."/>
<person name="Demirbilek H."/>
<person name="Ucar A."/>
<person name="Isik E."/>
<person name="Ozhan B."/>
<person name="Bolu S."/>
<person name="Ozgen I.T."/>
<person name="Suntharalingham J.P."/>
<person name="Achermann J.C."/>
</authorList>
<dbReference type="PubMed" id="26523528"/>
<dbReference type="DOI" id="10.1210/jc.2015-3250"/>
</citation>
<scope>VARIANT AINR GLN-92</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Genet. Med." volume="19" first="367" last="376">
<title>NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development.</title>
<authorList>
<person name="Baetens D."/>
<person name="Stoop H."/>
<person name="Peelman F."/>
<person name="Todeschini A.L."/>
<person name="Rosseel T."/>
<person name="Coppieters F."/>
<person name="Veitia R.A."/>
<person name="Looijenga L.H."/>
<person name="De Baere E."/>
<person name="Cools M."/>
</authorList>
<dbReference type="PubMed" id="27490115"/>
<dbReference type="DOI" id="10.1038/gim.2016.118"/>
</citation>
<scope>VARIANT SRXX4 TRP-92</scope>
<scope>CHARACTERIZATION OF VARIANT SRXX4 TRP-92</scope>
<scope>INVOLVEMENT IN SRXX4</scope>
<scope>CHARACTERIZATION OF VARIANT SRXY3 GLN-92</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Horm. Res. Paediatr." volume="87" first="191" last="195">
<title>A 46,XX ovotesticular disorder of sex development likely caused by a steroidogenic factor-1 (NR5A1) variant.</title>
<authorList>
<person name="Swartz J.M."/>
<person name="Ciarlo R."/>
<person name="Guo M.H."/>
<person name="Abrha A."/>
<person name="Weaver B."/>
<person name="Diamond D.A."/>
<person name="Chan Y.M."/>
<person name="Hirschhorn J.N."/>
</authorList>
<dbReference type="PubMed" id="27855412"/>
<dbReference type="DOI" id="10.1159/000452888"/>
</citation>
<scope>INVOLVEMENT IN SRXX4</scope>
<scope>VARIANT SRXX4 GLN-92</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2016" name="Hum. Mol. Genet." volume="25" first="3446" last="3453">
<title>A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development.</title>
<authorList>
<consortium name="Members of UDN"/>
<person name="Bashamboo A."/>
<person name="Donohoue P.A."/>
<person name="Vilain E."/>
<person name="Rojo S."/>
<person name="Calvel P."/>
<person name="Seneviratne S.N."/>
<person name="Buonocore F."/>
<person name="Barseghyan H."/>
<person name="Bingham N."/>
<person name="Rosenfeld J.A."/>
<person name="Mulukutla S.N."/>
<person name="Jain M."/>
<person name="Burrage L."/>
<person name="Dhar S."/>
<person name="Balasubramanyam A."/>
<person name="Lee B."/>
<person name="Dumargne M.C."/>
<person name="Eozenou C."/>
<person name="Suntharalingham J.P."/>
<person name="de Silva K."/>
<person name="Lin L."/>
<person name="Bignon-Topalovic J."/>
<person name="Poulat F."/>
<person name="Lagos C.F."/>
<person name="McElreavey K."/>
<person name="Achermann J.C."/>
</authorList>
<dbReference type="PubMed" id="27378692"/>
<dbReference type="DOI" id="10.1093/hmg/ddw186"/>
</citation>
<scope>INVOLVEMENT IN SRXX4</scope>
<scope>INVOLVEMENT IN SRXY3</scope>
<scope>VARIANT SRXX4 TRP-92</scope>
<scope>VARIANT SRXY3 TRP-92</scope>
<scope>CHARACTERIZATION OF VARIANT SRXX4 TRP-92</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="39" last="42">
<title>Identical NR5A1 missense mutations in two unrelated 46,XX individuals with testicular tissues.</title>
<authorList>
<person name="Igarashi M."/>
<person name="Takasawa K."/>
<person name="Hakoda A."/>
<person name="Kanno J."/>
<person name="Takada S."/>
<person name="Miyado M."/>
<person name="Baba T."/>
<person name="Morohashi K.I."/>
<person name="Tajima T."/>
<person name="Hata K."/>
<person name="Nakabayashi K."/>
<person name="Matsubara Y."/>
<person name="Sekido R."/>
<person name="Ogata T."/>
<person name="Kashimada K."/>
<person name="Fukami M."/>
</authorList>
<dbReference type="PubMed" id="27610946"/>
<dbReference type="DOI" id="10.1002/humu.23116"/>
</citation>
<scope>VARIANT SRXX4 TRP-92</scope>
<scope>CHARACTERIZATION OF VARIANT SRXX4 TRP-92</scope>
<scope>INVOLVEMENT IN SRXX4</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2017" name="PLoS ONE" volume="12" first="E0176720" last="E0176720">
<title>New NR5A1 mutations and phenotypic variations of gonadal dysgenesis.</title>
<authorList>
<person name="Werner R."/>
<person name="Moenig I."/>
<person name="Luenstedt R."/>
<person name="Wuensch L."/>
<person name="Thorns C."/>
<person name="Reiz B."/>
<person name="Krause A."/>
<person name="Schwab K.O."/>
<person name="Binder G."/>
<person name="Holterhus P.M."/>
<person name="Hiort O."/>
</authorList>
<dbReference type="PubMed" id="28459839"/>
<dbReference type="DOI" id="10.1371/journal.pone.0176720"/>
</citation>
<scope>VARIANTS SRXY3 18-ASP--GLY-22 DEL AND PRO-40</scope>
<scope>CHARACTERIZATION OF VARIANTS SRXY3 18-ASP--GLY-22 DEL AND PRO-40</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="3 16 25 29">Transcriptional activator. Essential for sexual differentiation and formation of the primary steroidogenic tissues (PubMed:27378692). Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1 (PubMed:27378692). The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. Binds phosphatidylcholine (By similarity). Binds phospholipids with a phosphatidylinositol (PI) headgroup, in particular PI(3,4)P2 and PI(3,4,5)P3. Activated by the phosphorylation of NR5A1 by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation.</text>
</comment>
<comment type="subunit">
<text evidence="3 10 13 14 16 17 19">Binds DNA as a monomer. Interacts with NR0B2 and PPARGC1A (By similarity). Part of a complex consisting of SFPQ, NONO and NR5A1. Interacts with NCOA2. Interacts with DGKQ and CDK7. Binds to and activated by HIPK3.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-739879">
<id>Q53TS8</id>
<label>C2CD6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-456371">
<id>P61024</id>
<label>CKS1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-946109">
<id>P51843</id>
<label>NR0B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-741158">
<id>Q96HA8</id>
<label>NTAQ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-712376">
<id>P40937</id>
<label>RFC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-874629">
<id>Q13285</id>
</interactant>
<interactant intactId="EBI-750487">
<id>Q8WW24</id>
<label>TEKT4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="4 9 26">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="30">High expressed in the adrenal cortex, the ovary, the testis, and the spleen (PubMed:9177385).</text>
</comment>
<comment type="PTM">
<text evidence="9">Acetylation stimulates the transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="12 20">Sumoylation reduces CDK7-mediated phosphorylation on Ser-203.</text>
</comment>
<comment type="PTM">
<text evidence="6 19 20">Phosphorylated on Ser-203 by CDK7. This phosphorylation promotes transcriptional activity.</text>
</comment>
<comment type="disease" evidence="7 11 15 18 23 25 26 29">
<disease id="DI-02465">
<name>46,XY sex reversal 3</name>
<acronym>SRXY3</acronym>
<description>A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype.</description>
<dbReference type="MIM" id="612965"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="25 26 27 28">
<disease id="DI-05002">
<name>46,XX sex reversal 4</name>
<acronym>SRXX4</acronym>
<description>A condition in which male gonads develop in a genetic female (female to male sex reversal).</description>
<dbReference type="MIM" id="617480"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="8 24">
<disease id="DI-05003">
<name>Adrenal insufficiency, NR5A1-related</name>
<acronym>AINR</acronym>
<description>A disorder characterized by adrenal insufficiency, muscular hypotonia, decreased sodium and increased potassium levels, elevated ACTH, salt-wasting crisis, prolonged jaundice, hypoglycemia, and vomiting.</description>
<dbReference type="MIM" id="612964"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-02517">
<name>Premature ovarian failure 7</name>
<acronym>POF7</acronym>
<description>An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol.</description>
<dbReference type="MIM" id="612964"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-03124">
<name>Spermatogenic failure 8</name>
<acronym>SPGF8</acronym>
<description>An infertility disorder characterized by spermatogenesis failure and severe oligozoospermia.</description>
<dbReference type="MIM" id="613957"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the nuclear hormone receptor family. NR5 subfamily.</text>
</comment>
<dbReference type="EMBL" id="D88155">
<property type="protein sequence ID" value="BAA13546.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U76388">
<property type="protein sequence ID" value="AAB53105.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137846">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL354979">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471090">
<property type="protein sequence ID" value="EAW87591.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032501">
<property type="protein sequence ID" value="AAH32501.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U32592">
<property type="protein sequence ID" value="AAA75332.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6856.1"/>
<dbReference type="PIR" id="JC4972">
<property type="entry name" value="JC4972"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004950.2">
<property type="nucleotide sequence ID" value="NM_004959.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005251928.1">
<property type="nucleotide sequence ID" value="XM_005251871.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516757.1">
<property type="nucleotide sequence ID" value="XM_011518455.2"/>
</dbReference>
<dbReference type="PDB" id="1YOW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=222-461"/>
</dbReference>
<dbReference type="PDB" id="1ZDT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=221-461"/>
</dbReference>
<dbReference type="PDB" id="4QJR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=218-461"/>
</dbReference>
<dbReference type="PDB" id="4QK4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A=218-461"/>
</dbReference>
<dbReference type="PDBsum" id="1YOW"/>
<dbReference type="PDBsum" id="1ZDT"/>
<dbReference type="PDBsum" id="4QJR"/>
<dbReference type="PDBsum" id="4QK4"/>
<dbReference type="SMR" id="Q13285"/>
<dbReference type="BioGRID" id="108792">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="CORUM" id="Q13285"/>
<dbReference type="IntAct" id="Q13285">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="MINT" id="Q13285"/>
<dbReference type="STRING" id="9606.ENSP00000362690"/>
<dbReference type="BindingDB" id="Q13285"/>
<dbReference type="ChEMBL" id="CHEMBL4666"/>
<dbReference type="DrugBank" id="DB04683">
<property type="generic name" value="(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE"/>
</dbReference>
<dbReference type="DrugBank" id="DB04752">
<property type="generic name" value="Phosphatidyl ethanol"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="632"/>
<dbReference type="iPTMnet" id="Q13285"/>
<dbReference type="PhosphoSitePlus" id="Q13285"/>
<dbReference type="BioMuta" id="NR5A1"/>
<dbReference type="DMDM" id="3121738"/>
<dbReference type="MassIVE" id="Q13285"/>
<dbReference type="PaxDb" id="Q13285"/>
<dbReference type="PeptideAtlas" id="Q13285"/>
<dbReference type="PRIDE" id="Q13285"/>
<dbReference type="ProteomicsDB" id="59276"/>
<dbReference type="Antibodypedia" id="16333">
<property type="antibodies" value="411 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2516"/>
<dbReference type="Ensembl" id="ENST00000373588">
<property type="protein sequence ID" value="ENSP00000362690"/>
<property type="gene ID" value="ENSG00000136931"/>
</dbReference>
<dbReference type="GeneID" id="2516"/>
<dbReference type="KEGG" id="hsa:2516"/>
<dbReference type="UCSC" id="uc004boo.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2516"/>
<dbReference type="DisGeNET" id="2516"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136931.9"/>
<dbReference type="GeneCards" id="NR5A1"/>
<dbReference type="GeneReviews" id="NR5A1"/>
<dbReference type="HGNC" id="HGNC:7983">
<property type="gene designation" value="NR5A1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136931">
<property type="expression patterns" value="Tissue enhanced (adrenal gland, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="NR5A1"/>
<dbReference type="MIM" id="184757">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="612964">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612965">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613957">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13285"/>
<dbReference type="OpenTargets" id="ENSG00000136931"/>
<dbReference type="Orphanet" id="243">
<property type="disease" value="46,XX gonadal dysgenesis"/>
</dbReference>
<dbReference type="Orphanet" id="2138">
<property type="disease" value="46,XX ovotesticular disorder of sex development"/>
</dbReference>
<dbReference type="Orphanet" id="393">
<property type="disease" value="46,XX testicular disorder of sex development"/>
</dbReference>
<dbReference type="Orphanet" id="242">
<property type="disease" value="46,XY complete gonadal dysgenesis"/>
</dbReference>
<dbReference type="Orphanet" id="251510">
<property type="disease" value="46,XY partial gonadal dysgenesis"/>
</dbReference>
<dbReference type="Orphanet" id="399805">
<property type="disease" value="Male infertility with azoospermia or oligozoospermia due to single gene mutation"/>
</dbReference>
<dbReference type="Orphanet" id="619">
<property type="disease" value="NON RARE IN EUROPE: Primary ovarian failure"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31764"/>
<dbReference type="eggNOG" id="KOG4218">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153391"/>
<dbReference type="HOGENOM" id="CLU_011437_0_0_1"/>
<dbReference type="InParanoid" id="Q13285"/>
<dbReference type="KO" id="K08560"/>
<dbReference type="OMA" id="KAECPDY"/>
<dbReference type="OrthoDB" id="619653at2759"/>
<dbReference type="PhylomeDB" id="Q13285"/>
<dbReference type="TreeFam" id="TF350737"/>
<dbReference type="PathwayCommons" id="Q13285"/>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-452723">
<property type="pathway name" value="Transcriptional regulation of pluripotent stem cells"/>
</dbReference>
<dbReference type="SignaLink" id="Q13285"/>
<dbReference type="SIGNOR" id="Q13285"/>
<dbReference type="BioGRID-ORCS" id="2516">
<property type="hits" value="11 hits in 898 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13285"/>
<dbReference type="GeneWiki" id="Steroidogenic_factor_1"/>
<dbReference type="GenomeRNAi" id="2516"/>
<dbReference type="Pharos" id="Q13285">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13285"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="Q13285">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136931">
<property type="expression patterns" value="Expressed in right adrenal gland cortex and 75 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13285">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13285">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005543">
<property type="term" value="F:phospholipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0030325">
<property type="term" value="P:adrenal gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097720">
<property type="term" value="P:calcineurin-mediated signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008585">
<property type="term" value="P:female gonad development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042445">
<property type="term" value="P:hormone metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009755">
<property type="term" value="P:hormone-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001553">
<property type="term" value="P:luteinization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051457">
<property type="term" value="P:maintenance of protein location in nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008584">
<property type="term" value="P:male gonad development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030238">
<property type="term" value="P:male sex determination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010259">
<property type="term" value="P:multicellular organism aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000195">
<property type="term" value="P:negative regulation of female gonad development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000020">
<property type="term" value="P:positive regulation of male gonad development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007538">
<property type="term" value="P:primary sex determination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050810">
<property type="term" value="P:regulation of steroid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097210">
<property type="term" value="P:response to gonadotropin-releasing hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007530">
<property type="term" value="P:sex determination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009888">
<property type="term" value="P:tissue development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00072"/>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016355">
<property type="entry name" value="NR5_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24086">
<property type="entry name" value="PTHR24086"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF002530">
<property type="entry name" value="Nuc_orph_FTZ-F1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1066">Premature ovarian failure</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Steroidogenic factor 1" id="PRO_0000053729">
<location>
<begin position="1"/>
<end position="461"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="5">
<location>
<begin position="222"/>
<end position="459"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="4">
<location>
<begin position="10"/>
<end position="85"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="4">
<location>
<begin position="13"/>
<end position="33"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="4">
<location>
<begin position="49"/>
<end position="73"/>
</location>
</feature>
<feature type="region of interest" description="Important for dimerization">
<location>
<begin position="230"/>
<end position="461"/>
</location>
</feature>
<feature type="binding site" description="Lipid headgroup; via amide nitrogen">
<location>
<position position="341"/>
</location>
</feature>
<feature type="binding site" description="Lipid headgroup">
<location>
<position position="436"/>
</location>
</feature>
<feature type="binding site" description="Lipid headgroup">
<location>
<position position="440"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="33">
<location>
<position position="34"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="33">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="33">
<location>
<position position="72"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK7" evidence="6 19 20">
<location>
<position position="203"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="12">
<location>
<position position="119"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="12">
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure; dbSNP:rs104894124." id="VAR_063255" evidence="15">
<original>V</original>
<variation>M</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; loss of DNA-binding; significantly decreased transactivator activity." id="VAR_079571" evidence="29">
<location>
<begin position="18"/>
<end position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure; markedly impaired transcriptional activity." id="VAR_039106" evidence="18">
<original>C</original>
<variation>S</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; with adrenal failure; dbSNP:rs121918654." id="VAR_004737" evidence="7">
<original>G</original>
<variation>E</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; loss of DNA-binding; significantly decreased transactivator activity." id="VAR_079572" evidence="29">
<original>T</original>
<variation>P</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure." id="VAR_078136" evidence="23">
<original>C</original>
<variation>Y</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure; dbSNP:rs104894125." id="VAR_063256" evidence="15">
<original>M</original>
<variation>I</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure; markedly impaired transcriptional activity; dbSNP:rs375469069." id="VAR_039107" evidence="18">
<original>R</original>
<variation>H</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure; dbSNP:rs104894126." id="VAR_063257" evidence="15">
<original>G</original>
<variation>S</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3, SRXX4 and AINR; decreased transactivator activity; no effect on nuclear location; dbSNP:rs104894119." id="VAR_016982" evidence="11 24 26 28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3 and SRXX4; decreased transactivator activity; loss of DNA binding, at least to some known consensus target sequences; no effect on nuclear location; dbSNP:rs886039769." id="VAR_078137" evidence="25 26 27">
<original>R</original>
<variation>W</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In SPGF8 and POF7; activity levels similar to wild-type; dbSNP:rs200163795." id="VAR_062967" evidence="21 22">
<original>G</original>
<variation>A</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In SPGF8 and POF7; loss of activity; dbSNP:rs200749741." id="VAR_062968" evidence="21 22">
<original>P</original>
<variation>L</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In SPGF8; impairs transactivational activity; dbSNP:rs387906690." id="VAR_065866" evidence="22">
<original>P</original>
<variation>L</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1110061." id="VAR_039108" evidence="18 21">
<original>G</original>
<variation>A</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In SPGF8; impairs transactivational activity; dbSNP:rs1253324106." id="VAR_065867" evidence="22">
<original>R</original>
<variation>C</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In SPGF8; impairs transactivational activity; dbSNP:rs201095702." id="VAR_065868" evidence="22">
<original>G</original>
<variation>S</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In POF7." id="VAR_062969" evidence="21">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In SPGF8; impairs transactivational activity; dbSNP:rs780568525." id="VAR_065869" evidence="22">
<original>D</original>
<variation>N</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In AINR; dbSNP:rs104894118." id="VAR_016983" evidence="8">
<original>R</original>
<variation>L</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In POF7; without adrenal failure; partial loss of activity; dbSNP:rs121918655." id="VAR_062970" evidence="21">
<original>D</original>
<variation>N</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In SRXY3; without adrenal failure; dbSNP:rs104894120." id="VAR_063258" evidence="15">
<original>L</original>
<variation>Q</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation; when associated with R-194." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced transactivation." evidence="14">
<original>A</original>
<variation>F</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transactivation. Strongly reduced transactivation; when associated with F-344." evidence="14">
<original>G</original>
<variation>E</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transactivation. Strongly reduced transactivation; when associated with E-341." evidence="14">
<original>L</original>
<variation>F</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced transactivation." evidence="14">
<original>A</original>
<variation>F</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transactivation; when associated with A-440." evidence="14">
<original>Y</original>
<variation>F</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transactivation; when associated with F-436." evidence="14">
<original>K</original>
<variation>A</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA13546." ref="1" evidence="32">
<original>K</original>
<variation>N</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="225"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="239"/>
<end position="243"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="262"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="286"/>
<end position="288"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="291"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="333"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="342"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="365"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="387"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="411"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="415"/>
<end position="442"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="451"/>
<end position="456"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YOW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZDT"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P33242"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10230405"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10369247"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11038323"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11479297"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11897684"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11932325"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15192080"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15707893"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15897460"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17200175"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17210646"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17664281"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17694559"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17901130"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19015234"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19246354"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20887963"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24405868"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26523528"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27378692"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27490115"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27610946"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27855412"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28459839"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9177385"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8938589"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11479297"/>
</source>
</evidence>
<sequence length="461" mass="51636" checksum="622644C62794826C" modified="1998-01-01" version="2">MDYSYDEDLDELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKHYTCTESQSCKIDKTQRKRCPFCRFQKCLTVGMRLEAVRADRMRGGRNKFGPMYKRDRALKQQKKAQIRANGFKLETGPPMGVPPPPPPAPDYVLPPSLHGPEPKGLAAGPPAGPLGDFGAPALPMAVPGAHGPLAGYLYPAFPGRAIKSEYPEPYASPPQPGLPYGYPEPFSGGPNVPELILQLLQLEPDEDQVRARILGCLQEPTKSRPDQPAAFGLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQNCWSELLVFDHIYRQVQHGKEGSILLVTGQEVELTTVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFSLDLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLLLCLVEVRALSMQAKEYLYHKHLGNEMPRNNLLIEMLQAKQT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

